Technology Database Agriculture INCAPSULATED BIOINSECTICIDES ON THE BASE OF RECOMBINANT PSEUDOMONAS STRAINS WITH INDUCED EXPRESSION OF CRYIII-GENE AGAINST COLORADO BEATLES
INCAPSULATED
BIOINSECTICIDES ON THE BASE OF RECOMBINANT PSEUDOMONAS STRAINS WITH INDUCED
EXPRESSION OF CRYIII-GENE AGAINST COLORADO BEATLES
Recombinant strains of
Pseudomonas spp. were constructed for the development of paint-protection
preparations against Coleoptera insects.
These strains are adaptable for
manufacturing (they have a high growth rate, the components of nutrient media
for their cultivation are accessible), show Coleoptera-specific insecticide
activity, which is determined by Bacilus thuringiensis subsp. tenebrionis gene.
In contrast to B.thuringiensis, crystalline protein synthesized by recombinant
Pseudomonas, is localized inside the cell, thus being protected by the cell
envelope from the influence of a number of damaging environmental factors.
Negative effect of the endotoxin of the liability of the recombinant strains was
decreased due to the system of induced cryIII-gene expression. The use of
recombinant Pseudomonas strains as advanced enthomotoxin producers is thus
determined by the properties of recipient strains and possibility to optimize
the procedure of cultivation. Production of delta-endotoxin by recombinant
Pseudomonas strains reaches 60-70% of the total amount of cell protein. However,
the induction of cryIII-determinant expression is Pseudomonas may result in the
inhibition of cell population growth and destabilization of the recombinants and
toxin synthesis induction.
The preparation of a patent (Application
N 95119335) for P.putida IPM-36 as a producer of incapsulated bioinsecticide
against Colorado Beatles and for me technology of its construction is in
progress now.
Publishing date: February 27, 2001
To make an inquiry on the technology you are interested in
Back
|